Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
opioid analgesic
|
| gptkbp:associatedWith |
dependence
addiction risk overdose risk |
| gptkbp:availableIn |
tablet
syrup |
| gptkbp:built |
gptkb:codeine
poppy plant |
| gptkbp:chemicalFormula |
CYP2D6
C18H21NO3P |
| gptkbp:contraindication |
respiratory depression
severe asthma intestinal obstruction |
| gptkbp:dosageForm |
oral solution
injectable solution |
| https://www.w3.org/2000/01/rdf-schema#label |
codeine phosphate
|
| gptkbp:impact |
central nervous system
pain perception cough reflex |
| gptkbp:interactsWith |
alcohol
benzodiazepines muscle relaxants |
| gptkbp:isRecognizedFor |
pregnant women
children under 12 breastfeeding women |
| gptkbp:isResponsibleFor |
with prolonged use
|
| gptkbp:lastProduced |
1950s
|
| gptkbp:legalStatus |
controlled substance
|
| gptkbp:locatedIn |
19th century
|
| gptkbp:notableFeature |
Phenergan with Codeine
Tylenol with Codeine Robitussin_AC |
| gptkbp:offersCoursesIn |
gptkb:Australia
gptkb:Canada gptkb:United_Kingdom gptkb:United_States |
| gptkbp:packaging |
blister pack
bottle |
| gptkbp:predecessor |
morphine
|
| gptkbp:route |
oral
intravenous |
| gptkbp:sideEffect |
nausea
drowsiness constipation |
| gptkbp:suitableFor |
varies by condition
usually 15-60 mg every 4-6 hours |
| gptkbp:symptoms |
anxiety
muscle pain insomnia |
| gptkbp:usedFor |
pain relief
cough_suppression |